A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 121
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NOM
Long Form : normal oral mucosa
No. Year Title Co-occurring Abbreviation
2020 A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma. AB, CDK
2020 Altered expression of CCN1 in oral lichen planus associated with keratinocyte activation and IL-1beta, ICAM1, and CCL5 up-regulation. OLP
2020 Assessing the Expression of Aquaporin 3 Antigen-Recognition Sites in Oral Squamous Cell Carcinoma. aa, AQP3, AQP3 AR, HG-ED, OSCC
2020 BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation. Dys OL, IH, OL, OSCC
2020 CD146 expression in oral lichen planus and oral cancer. OED, OLP, OSCC
2020 Expression of nucleotide-binding oligomerization domain 1 and 2 in oral lichen planus. IFH, NOD, OLP
2020 Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan. LIs, NPM1, OED, OSCC
2019 Activation of BDNF/TrkB/Akt pathway is associated with aggressiveness and unfavorable survival in oral squamous cell carcinoma. BDNF, OL, OSCC, rpS6, TrkB
2019 Bcl-2 expression in reactive oral lesions with atypical epithelium and in oral epithelial dysplasia associated with carcinogen exposure. OED
10  2019 Isolation and characterization of cells derived from human epithelial rests of Malassez. ERMs
11  2019 Ki67, CD105 and alpha-smooth muscle actin expression in disease progression model of oral submucous fibrosis. alpha-SMA, HRED, LI, LRED, OSCC-SMF, OSF, WDSCC
12  2019 Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study. ANOVA, OSCC
13  2019 The importance of inducible nitric oxide synthase and nitrotyrosine as prognostic markers for oral squamous cell carcinoma. NO, OL, OSCC, qPCRs
14  2019 Tunicamycin-induced endoplasmic reticulum stress up-regulates tumour-promoting cytokines in oral squamous cell carcinoma. ERS, IL-6R, NOK, OSCC, STAT
15  2019 Upregulation of eukaryotic translation initiation factor 3 subunit a promotes cell survival in ameloblastoma. AB, eIF3a
16  2018 CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma. CD, LR-OLK, OLK, OSCC
17  2018 Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders. IHC, OED, OPMDs, OSCC, OSMF, QS
18  2018 Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study. MVD, OSF
19  2018 Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa. ECM, MVAP, MVD, OED, OSCC
20  2018 Evaluation of mast cells in oral premalignant and malignant lesions: A histochemical study. OSCC
21  2018 Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. IHC, MUC1, OSCC
22  2018 Expression of WNT1 in ameloblastoma and its significance. AB, KCOT, RT-qPCR
23  2018 Identification of alpha-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis. IHC, MS/MS, OSCC, OSF, OSFWD, OSFWT, RT-PCR, WB
24  2018 Immunohistochemical evaluation of tumor angiogenesis and the role of mast cells in oral squamous cell carcinoma. MCD, MVD, OSCC
25  2018 Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. EMMPRIN, OED, OSCC
26  2018 Ki67, CD105, and alpha-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis. OSMF
27  2018 MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma. FFPE, miRNAs, OSCC, qPCR
28  2018 Overexpression of sprouty2 in human oral squamous cell carcinogenesis. MT, NOMPC, OCCLs, OPMDs, OSCCs
29  2018 Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. EMT, LN, OSCC
30  2017 Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer. EMT, OL, OSCC
31  2017 Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. IMP3, OSF
32  2017 Immunohistochemical analysis of stromal fibrocytes and myofibroblasts to envision the invasion and lymph node metastasis in oral squamous cell carcinoma. alpha-SMA, OSCC
33  2017 Ki67, CD105, and alpha-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization. LI, LRED, MVD, OED, OPMDs
34  2017 Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters. LCs, OED
35  2017 Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3. NC, OSCC
36  2016 Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study. DKK3, OLK, OSCC, OSF, TSG
37  2016 CD1a+ dendritic cells in oral lichen planus and amalgam lichenoid reaction. ALR, DCs, OLP
38  2016 Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. OSCC, PMDs
39  2016 Myeloid cell leukemia-1 is a molecular indicator for malignant transformation of oral lichen planus. Bcl-2, Mcl-1, OLP
40  2015 A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa. MGP, OL, OSCC, OSMF
41  2015 Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival. EMT, OSCC
42  2015 Comparing The Efficacy of Hematoxylin and Eosin, Periodic Acid Schiff and Fluorescent Periodic Acid Schiff-Acriflavine Techniques for Demonstration of Basement Membrane in Oral Lichen Planus: A Histochemical Study. BM, HE, OLP, PAS
43  2015 Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines. DAPI, OSCC
44  2015 Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. OL, OLP, OSCC, OSMF
45  2015 Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma. AB, OSCC, p-Akt
46  2015 GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma. OED, OSCC, VC
47  2015 Histomorphometric study to compare histological changes between oral squamous cell carcinoma and apparently normal adjacent oral mucosa. ANM, OSCC
48  2015 Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions. LIs, Mcm-2, MCM2, OBK, OED, OSCC
49  2015 Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis. OL, OSMF, PMDs
50  2015 The Activation of NF-kappaB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus. NF-kappaB, OLP, Treg
51  2014 Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas. ABs
52  2014 Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma. LIs, OSCC
53  2014 Silver binding nucleolar organizer regions dots in oral leukoplakia with epithelial dysplasia and oral squamous cell carcinoma: an in vivo study. ED, OSCC
54  2013 Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia. OED
55  2013 Computational analysis of p63(+) nuclei distribution pattern by graph theoretic approach in an oral pre-cancer (sub-mucous fibrosis). OSCC, OSF, OSFWD, OSFWT
56  2013 COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. COX, OLP, OSCC
57  2013 Expression of Galpha12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan. OED, OSCC
58  2013 Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study. IHC, OED, OSCC, TLRs
59  2013 Immunohistochemical study of integrin alpha₅beta₁, fibronectin, and Bcl-2 in normal oral mucosa, inflammatory fibroepithelial hyperplasia, oral epithelial dysplasia, and oral squamous cell carcinoma. IFH, OED, OSCC
60  2013 Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. AUC, MD, OSCC
61  2013 Upregulation of epidermal growth factor receptor 4 in oral leukoplakia. EGFR, LP, OLP, PCR
62  2012 Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. ABs, DC, FOM, KCOT, LI
63  2012 Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa. alpha-SMA, HRED, LRED, OSCC, VC
64  2012 Computer vision approach to morphometric feature analysis of basal cell nuclei for evaluating malignant potentiality of oral submucous fibrosis. FD, OSFD
65  2012 Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. MDM2, OIS, OSCC
66  2012 Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation. OSCC, OSMF
67  2012 Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. Mild ED, Mod ED, MVD, SCC, SED, VEGF
68  2012 Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma. OSCC, TFF
69  2012 Novel MDM2 splice variants identified from oral squamous cell carcinoma. OSCC, PCR
70  2011 Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD-105 antigen. DC, KCOT, Ki-67 LI, MVA, MVD, TVA
71  2010 Structural markers for normal oral mucosa and oral sub-mucous fibrosis. OSF
72  2010 Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. AREG, EGFR, EREG, HB-EGF, OLP
73  2009 A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma. MAGE-A, OSCC, RT-PCR
74  2009 Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. NF-kappaB, OLP, TNF-alpha
75  2009 Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. EpCAM, LIs, OSCC
76  2009 Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. LI, OSCC
77  2009 Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. LIs, MCM2, OED, OSCC
78  2009 Improved diagnosis of oral premalignant lesions in submucous fibrosis patients with 5-aminolevulinic acid induced PpIX fluorescence. ED, EH, OSF
79  2009 Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development. Gal-1, OPL, OSCC
80  2009 [Expressions of proliferating cell nuclear antigen, Bcl-2, and Bax in lymphocytes of patients with oral lichen planus]. Bax, Bcl-2, OLP, PCNA
81  2009 [Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions]. OLK, OLP, OSCC, RIP
82  2008 An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. ED, EGFR, IHC, OSCC
83  2008 Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. HIF-1alpha, LIs, OSCC
84  2008 Expression of MAGE-A12 in oral squamous cell carcinoma. MAGE-A, OSCC, RT-nPCR
85  2008 Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. LIs, OSCC
86  2008 NGF and its receptors TrkA and p75NTR in the epithelium of oral lichen. ERY, NGF, OL, p-Akt
87  2008 Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis. OSCC, OSF
88  2008 [Expression of TGF-beta1, Smad7 and cell apoptosis in epithelium of oral lichen planus]. AI, OLP
89  2007 Changes in the expression of stem cell markers in oral lichen planus and hyperkeratotic lesions. MCSP, OLP
90  2007 Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. hTERT, OED, SI
91  2007 Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. SCC, VEGF
92  2007 Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. OPM, OSCC, TIL, TRAIL
93  2007 Survival signalling in keratinocytes of erythematous oral lichen planus. OL, TNF-alpha
94  2006 Cell proliferation and p53 expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis. ED, PCMycosis, PEH
95  2006 Cytokeratin expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis. CKs
96  2006 Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. E-cad, OPLs, OSCC
97  2006 [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma]. AB, KCOT
98  2005 Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. CRYAB
99  2005 Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. AQ, ED, EH, LI, OLP, PCNA, SCC
100  2005 Time-resolved autofluorescence spectroscopy for classifying normal and premalignant oral tissues. ED, EH, FDA, VH